Loading...
Chimera Investment Corp (CIM) is not a strong buy for a beginner, long-term investor with $50,000-$100,000 to invest. The stock lacks strong positive catalysts, has weak financial performance, and recent analyst downgrades indicate limited growth potential. While technical indicators are neutral and options data shows balanced sentiment, there is no compelling reason to buy at this time.
The MACD is slightly positive at 0.0428 but contracting, RSI is neutral at 62.115, and moving averages are converging, indicating no clear trend. Support is at 13.186, resistance at 14.022, with the current price at 13.59. The stock shows no strong technical signals for immediate action.

No significant positive catalysts. The company is diversifying its revenue streams, which could be beneficial long-term.
Recent analyst downgrade by RBC Capital citing lower expected ROE compared to peers. Financial performance in Q4 2025 showed a significant drop in net income (-103.86% YoY) and EPS (-103.40% YoY). Gross margin also declined by 16.41%.
In Q4 2025, revenue increased by 10.48% YoY to $222.67M. However, net income dropped significantly to $6.5M (-103.86% YoY), and EPS fell to 0.07 (-103.40% YoY). Gross margin decreased to 28.07% (-16.41% YoY), indicating declining profitability.
RBC Capital downgraded the stock to Sector Perform from Outperform with a price target of $13, citing lower expected ROE in 2026 compared to peers. Analysts see better relative value in other mortgage REITs.